Anchorage-independent growth is a hallmark of tumor growth and results from enhanced proliferation and altered cell-cell and cell-matrix interactions. By using genedeficient mouse embryonic fibroblasts (MEFs), we showed for the first time that NHERF1/EBP50 (Na/H exchanger regulator factor 1/ezrin-radixin-moesin binding phosphoprotein 50), an adapter protein with membrane localization under physiological conditions, inhibits cell motility and is required to suppress anchorage-independent growth. Both NHERF1 PDZ domains are necessary for the tumor suppressor effect. NHERF1 associates directly through the PDZ2 domain with b-catenin and is required for b-catenin localization at the cell-cell junctions in MEFs. Mechanistically, the absence of NHERF1 selectively decreased the interaction of b-catenin with E-cadherin, but not with N-cadherin. The ensuing disorganization of E-cadherinmediated adherens junctions as well as the observed moderate increase in b-catenin transcriptional activity contributed most likely to the anchorage-independent growth of NHERF1-deficient MEFs. In vivo, NHERF1 is specifically localized at the apical brush-border membrane in intestinal epithelial cells and is required to maintain a fraction of the cortical b-catenin at this level. Thus, NHERF1 emerges as a cofactor essential for the integrity of epithelial tissues by maintaining the proper localization and complex assembly of b-catenin.
Introduction
Transformed cells lack normal cell contact inhibition and they grow in the absence of anchorage to the extracellular matrix owing to alterations in cell surface molecules such as cadherins and integrins (Thiery, 2002) . Cadherins constitute a major family of transmembrane glycoproteins that mediate cell-cell adhesion. Adjacent cells in tissues are linked by the interaction of cadherin extracellular domains, but the strength of the binding is supported by cytoplasmic interactions, which include those with catenins and thereby the actin cytoskeleton (Provost and Rimm, 1999) . This intracellular cluster of proteins is central to the assembly and function of adherens junctions and the large complex is composed of many components, of which b-catenin and p120 catenin bind directly to the cytoplasmic tail of cadherins (McCrea and Gumbiner, 1991; Reynolds et al., 1994) . b-catenin additionally acts as a transcriptional activator in the Wnt pathway (Nelson and Nusse, 2004) . Deregulation of Wnt signaling has been found in different types of cancer, in particular in colon cancer where, most frequently, mutations in APC lead to decreased protein turnover and cytoplasmic accumulation of b-catenin (Giles et al., 2003) . Following translocation to the nucleus, b-catenin relieves T-cell factor/lymphoid enhancer factor (TCF/LEF)-mediated transcriptional repression to activate several oncogenes and other gene targets. Although the regulation of b-catenin subcellular localization is a matter of extensive investigation (Brembeck et al., 2004; Gottardi and Gumbiner, 2004) , mechanisms of b-catenin shuttling between the membrane and cytoplasmic or nuclear complexes are only beginning to be understood.
b-Catenin was shown to bind in vitro and in vivo through its C-terminal PDZ motif to Na/H exchanger regulator factor 1/ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 (NHERF1/EBP50) (Shibata et al., 2003) that contains two PDZ domains and an ERMbinding region (Reczek et al., 1997; Weinman et al., 2003) . NHERF1 is involved in the regulation of ion transporters and in the trafficking of many transmembrane molecules (Shenolikar et al., 2004) , but its role in cancer is still controversial. NHERF1 gene mutations found with low frequency (3%) in breast cancer cell lines and primary tumors were associated with loss of heterozygosity and increased aggressiveness (Dai et al., 2004) , suggesting a tumor suppressor role for NHERF1. In contrast, Shibata et al. (2003) reported that the NHERF1/b-catenin complex promotes Wnt signaling and may cooperate in the development of liver cancer. To clarify the role of NHERF1, we analysed the growth properties of mouse embryonic fibroblasts (MEFs) generated from NHERF1-deficient mice (Morales et al., 2004) . We found that NHERF1(À/À) immortalized MEFs, in contrast to their wild-type counterparts, presented anchorage-independent growth. In NHERF1 (À/À) cells, b-catenin was delocalized from the plasma membrane to the cytoplasm and formed weaker complexes with E-cadherin. Our results point to a tumor suppressor role for NHERF1 via stabilization of b-catenin/ E-cadherin complexes at the plasma membrane.
Results
Loss of NHERF1 confers anchorage-independent growth to immortalized cells To assess the role in tumor development of NHERF1, we immortalized NHERF1( þ / þ ) and (À/À) MEFs with SV40T antigens and characterized their growth properties. At confluence, immortalized MEFs appeared polygonal and more epithelial-like than their parental, non-immortalized counterparts (not shown). However, although immortalized NHERF1( þ / þ ) MEFs grew as a monolayer on both plastic or poly-D-lysine-coated glass surfaces, NHERF1(À/À) MEFs retracted and clustered in spheres on poly-D-lysine-coated glass coverslips ( Figure 1a ). Compared to NHERF1( þ / þ ) cells, (À/À) MEFs presented delayed spreading when plated on poly-D-lysine but not on collagen matrix (Figure 1b) , or on fibronectin (not shown). Unlike collagen or fibronectin, poly-D-lysine promotes adhesion by an integrin-independent mechanism based on electrostatic interactions with the cell membrane, suggesting integrinindependent membrane modifications of NHERF1 (À/À) cells. Importantly, immortalized NHERF1(À/À) cells were able to form colonies in soft agar (Figure 1c) , suggesting that the loss of NHERF1 promotes anchorage-independent growth. The analysis of the proliferation of parental and immortalized MEFs showed no significant difference between the parental counterparts and a reproducible moderate proliferation advantage for NHERF1(À/À) immortalized cells relative to ( þ / þ ) NHERF1 stabilizes b-catenin/E-cadherin complexes EL Kreimann et al cells (Figure 1d ). We also investigated the mobility of MEFs by wound-healing assay. NHERF1(À/À) cells migrated faster than their ( þ / þ ) counterparts, filling the scratch in 13 versus 16 h respectively (Figure 1e ), suggesting cytoskeletal changes in NHERF1(À/À) cells.
Human NHERF1 and a panel of domain-deletion mutants were reconstituted in NHERF1(À/À) immortalized MEFs (Figure 2a ). The proliferation rates of reconstituted cells and vector-control cells were found similar (Figure 2b) . These cells were thus tested for their ability to form colonies in soft agar (Figure 2c and d). Full-length NHERF1 suppressed the colony formation of NHERF1(À/À) cells, supportive of a tumor suppressor function for NHERF1. To the same extent, the mutant PDZ1-2, which lacks the ERMbinding (EB) region, suppressed colony formation, whereas all the other mutants had no effect or slightly increased growth in soft agar. Notably, the naturally occurring splice isoform I2 that lacks the PDZ2 domain (Morales et al., 2004) was unable to suppress growth, indicating that both PDZ domains are required for anchorage-independent growth suppression by NHERF1.
NHERF1 controls the intracellular distribution of b-catenin NHERF1 is known to bind multiple ligands through the PDZ1 domain, to NHE3 through both PDZ domains, and to b-catenin and Yap 65 specifically through the PDZ2 domain (Voltz et al., 2001; Weinman et al., 2003) . We confirmed in an overlay assay that b-Catenin binds to NHERF1-PDZ2 domain (Figure 3a) . b-Catenin associated to overexpressed NHERF1 full-length and PDZ1-2 mutant but not to the I2 isoform (Figure 3b ). The failure of this PDZ2-deleted isoform to suppress anchorage-independent growth (Figure 2c and d) raised the possibility that b-catenin might contribute to NHERF1's growth suppression. We therefore examined the subcellular distribution of b-catenin in NHERF1 ( þ / þ ) and (À/À) immortalized MEFs. Immunofluorescence analysis showed strong b-catenin staining at the membrane boundaries between adjacent NHERF1 ( þ / þ ) cells but not of NHERF1(À/À) cells (Figure 3c ). Furthermore, the fractionation of cellular proteins indicated a marked increase of b-catenin in the cytoplasmic fraction of NHERF1(À/À) cells (Figure 3d ). Although we could not detect nuclear b-catenin by immunofluorescence analysis, we measured the transactivation Expression of a short C-terminal fragment of Ncadherin that encompasses the binding site for b-catenin was shown to couple b-catenin in the cytoplasm and to prevent b-catenin entry and transactivation in the nucleus (Sadot et al., 1998) . We stably expressed this N-cadherin-CT fragment in NHERF1(À/À) MEFs and examined their growth in soft agar. Vector control and N-cadherin-CT expressing NHERF1(À/À) cells formed equivalent numbers of colonies in soft agar. Nevertheless, N-cadherin-CT expression significantly reduced the size of the colonies (Figure 4 ), indicating that b-catenin transactivation contributes to the anchorageindependent growth of NHERF1(À/À) MEFs.
In vivo, we have described previously structural defects of the brush-border membrane (BBM) of intestinal epithelial cells in NHERF1(À/À) mice (Morales et al., 2004) . Fractionation of intestinal BBM , cytoplasmic (C), membrane (M), cytoskeleton (Cs) and debris (D) fractions. By using this procedure, it is known that the nuclear fraction can be contaminated by membrane components and vice versa, whereas the cytoplasmic fraction is pure. This is shown here by using PARP as nuclear marker. The ratio between NHERF1(À/À) and ( þ / þ ) levels of b-catenin normalized to actin levels in the various fractions was graphically (Figure 6c) . Moreover, coimmunoprecipitation of p120 catenin and a-catenin with N-cadherin showed equal amounts in both cell types, indicating that the catenin complexes formed with N-cadherin are unchanged by NHERF1 (Figure 6b ).
To confirm that NHERF1 is responsible for increased association between b-catenin and E-cadherin, the complex formation was analysed in NHERF1(À/À) immortalized MEFs reconstituted with NHERF1 fulllength, I2 isoform or vector control. Cell reconstituted with NHERF1 full-length, but not with I2 or vector showed higher amounts of E-cadherin coimmunoprecipitated with b-catenin (Figure 6d ). The amounts of N-cadherin coimmunoprecipitated with b-catenin were equivalent in all cell types (Figure 6d) , indicating a preferential stabilization of b-catenin/E-cadherin complexes by NHERF1.
To confirm the importance of NHERF1 for b-catenin/E-cadherin complex formation in mammalian cells, we expressed short hairpin (sh) inhibitory RNA against NHERF1 in the human colon carcinoma SW480 cells that contain elevated NHERF1 levels and obtained approximately 50% depletion of NHERF1 (Figure 6e ). Reciprocal coimmunoprecipitations of b-catenin and E-cadherin showed weakened interaction between b-catenin and E-cadherin in NHERF1-depleted cells compared with control cells (Figure 6f) .
Decreased E-cadherin cell surface levels in NHERF1(À/À) cells The decrease of E-cadherin from the plasma membrane is a marker of epithelial cancer progression and correlates with cell transformation and increased invasiveness (Thiery, 2002) . We examined the levels of E-and N-cadherin from total cell lysates in both parental and immortalized MEFs. In general, parental MEFs presented similar levels of N-cadherin but lower levels of E-cadherin compared to matched immortalized MEFs (Figure 7a ). In both parental and immortalized MEFs, the absence of NHERF1 determined opposite variations of the total expression levels of cadherins, with increase in N-cadherin and decrease in E-cadherin (Figure 7a ). These variations of cadherin levels were not caused by changes in transcription, as determined by RT-PCR (not shown).
The immunofluorescence analysis showed in immortalized wild-type cells E-cadherin localization at the boundaries between adjacent cells in patches corresponding to punctate adherens junctions. In contrast, in NHERF1(À/À) cells, E-cadherin staining was perinuclear, being absent at cell-cell contacts. N-cadherin appeared at the cell boundaries in both NHERF1 ( þ / þ ) and (À/À) cells, with stronger staining at punctate adherens junctions in NHERF1(À/À) cells.
The quantification of cell surface protein levels by biotinylation showed significantly decreased E-cadherin levels, moderately decreased b-catenin levels and unchanged N-cadherin levels in NHERF1(À/À) versus ( þ / þ ) immortalized MEFs (Figure 7c) . In parental cells, N-cadherin and b-catenin surface levels presented opposite variations, with more N-cadherin and less b-catenin in NHERF1(À/À) (Figure 7d ). Altogether, these findings showed that loss of NHERF1 decreased Figure 4 N-cadherin C-terminal fragment partially suppressed the anchorage-independent growth of NHERF1(À/À) MEFs. Schematic representation of N-cadherin extracellular and intracellular domains and of the C-terminal (CT) fragment that binds to b-catenin. N-cadherin CT fragment or retroviral vector control was expressed in immortalized NHERF1(À/À) MEFs. Cells were assayed for anchorage-independent growth by soft agar assay as in Figure 1c . The size of colonies was measured (legend) and the size distribution was graphically represented as percentage of total number of colonies. Significant differences between vector and N-cadherin-CT-expressing cells were obtained for the development of small size colonies (Pp0.005) and large size colonies (Pp0.01). This experiment was repeated twice with similar results.
NHERF1 stabilizes b-catenin/E-cadherin complexes EL Kreimann et al both b-catenin and E-cadherin levels from the plasma membrane, whereas N-cadherin levels either remained unchanged or increased.
Discussion
The importance of NHERF1 for ion transporter regulation, stabilization of transmembrane receptors to the plasma membrane and organization of the epithelial apical microvilli is well documented (Morales et al., 2004; Shenolikar et al., 2004) . These functions rely on the interaction of NHERF1 with transmembrane partners through the PDZ domains and with ERM proteins through the EB region. Recently, a role for NHERF1 in cancer emerged but it is still not clear whether as an oncogene or as a tumor suppressor (Shibata et al., 2003; Dai et al., 2004) . We show here that NHERF1 acts as a tumor suppressor and is required to suppress anchorage-independent growth.
Using reconstitution experiments of various NHERF1 domains in NHERF1-deficient cells, we found that both PDZ domains are required for growth suppression. In contrast to the PDZ1 domain that accounts for the majority of NHERF1 heterotypic associations, the PDZ2 domain interacts specifically with only few partners that include b-catenin (Shibata et al., 2003) . Involved extensively cancer progression, especially of colon carcinoma, b-catenin engages in various protein complexes in membrane, cytoplasmic and nuclear compartments (Nelson and Nusse, 2004) . This cellular compartmentalization dictates b-catenin's functions, as a tumor suppressor at the membrane where it interacts with E-cadherin and stabilizes adherens junctions, or as an oncogene in the nucleus where, following Wnt signaling or perhaps release from the membrane, complexes with TCF/LEF transcription factors and transactivates genes including oncogenes (Giles et al., 2003) . We found that NHERF1 is necessary for bcatenin stabilization at the plasma membrane. In MEFs, NHERF1 stabilizes b-catenin/E-cadherin complexes EL Kreimann et al NHERF1 deficiency impaired the localization of b-catenin at the cell-cell junctions. In intestinal epithelial cells where NHERF1 is localized at the apical BBM, b-catenin was specifically reduced apically in NHERF1 (À/À) mice. A macroscopic defect of NHERF1(À/À) mice is the increased length of the small intestine (data not shown). We currently examine whether the increased intestine length could result from defects of the apical membrane with compensatory intestine elongation or from b-catenin redistribution from the apical membrane to the cytoplasm and nucleus with increased Wnt/ b-catenin pathway activation and intestinal cell proliferation. Both parental and immortalized NHERF1(À/À) MEFs had E-cadherin levels significantly reduced compared to NHERF1( þ / þ ) MEFs. In contrast, the N-cadherin levels slightly increased in NHERF1(À/À) cells, reminiscent of the process of epithelial to mesenchymal transition that leads to mesenchymal appearance and increased motility of epithelial cells (Thiery, 2002) . Although the appearance of the cells was not modified, NHERF1(À/À) cells migrated faster than their wild-type counterparts and clustered in spheres, suggesting loss of cell-cell contact inhibition. NHERF1(À/À) immortalized MEFs also proliferated more than their wild-type counterparts. This proliferative advantage might be caused in part by the enhancement of b-catenin's transactivation ability, but probably also by loss of NHERF1 interactions with other binding partners. In this respect, we reported that NHERF1 attenuates the PI3K growth promoting signaling downstream of PDGFR by an interaction between its PDZ1 domain and PTEN tumor suppressor (Takahashi et al., 2006) . A simplified mechanistic model of how membrane-localized NHERF1 might suppress tumor growth is presented in Figure 8 . Pharmacological inhibition of PDGFR signaling (Supplementary Figure 1) as well as inhibition of b-catenin transactivation by a dominantnegative N-cadherin fragment impaired the anchorageindependent growth of NHERF1(À/À) MEFs, arguing for NHERF1's growth suppression via multiple pathways downstream of signaling proteins that interact with its PDZ domains.
NHERF1 deficiency decreased the interaction between b-catenin and E-cadherin in MEFs and in colon carcinoma SW480 cells but had no effect on the b-catenin/N-cadherin complex. These observations suggested that although b-catenin formed a stable complex with N-cadherin, it required association with NHERF1 to form a stable complex with E-cadherin. We do not know yet the mechanism by which NHERF1 selectively stabilized the b-catenin/E-cadherin complexes. NHERF1 was shown to stabilize at the cell surface transmembrane proteins with which it directly associated either by decreasing their endocytosis or by increasing their recycling to the plasma membrane (Shenolikar et al., 2004) . Here, NHERF1 might stabilize E-cadherin by what appears to be an indirect mechanism involving interaction with b-catenin. It is conceivable that NHERF1 inhibits the endocytosis of the b-catenin/E-cadherin complex. Alternatively, as mutagenesis of the b-catenin-binding site prevented E-cadherin processing and transport to the plasma membrane (Chen et al., 1999) , NHERF1 could influence the b-catenin/E-cadherin complex assembly and trafficking from ER to the plasma membrane. As cadherin switching is now well accepted to play a central role in both developmental and pathological conditions (Takeichi, 1995; Thiery, 2002) , further studies will address the NHERF1 stabilizes b-catenin/E-cadherin complexes EL Kreimann et al mechanism of differential regulation of E-cadherin versus N-cadherin levels and complexes by NHERF1. This will clarify the mechanism by which NHERF1 modulates cell adhesion and motility with impact on both normal development and cancer progression.
Materials and methods

Plasmids
For MEF immortalization, the SV40-T-antigens (gift from Tomoyuki Shishido) were used as described (Suzuki et al., 2004) . Human NHERF1 full-length (FL) and deletion mutants I2, PDZ1iP, PDZ2, PDZ2-EB and PDZ1-2 were cloned in pCX b retroviral vector and in pGEX-6P-1 vector for recombinant protein expression. A b-catenin fragment encoding the last 100 amino acids was inserted into pGEX-Myc vector. An N-cadherin fragment encoding the last 70 residues was inserted into pCX b -Myc vector. NHERF1 shRNA#1 (ACCCCATCCTAGACTTCAA) and control EGFP shRNA (gift from Tsuyoshi Akagi) were cloned in pSIREN-RetroQ vector.
Cells, retroviral infection, soft agar, cell spreading and migration assays Bosc23, SW480 and MEFs were grown in DME medium. Opossum kidney (OKP) cells (gift from Patricia Preisig) were grown in 1:1 mixture of low glucose DMEHam's F12 media. Retroviral infections and soft-agar assays were described (Georgescu et al., 1999) . For spreading assays, 5 Â 10 4 cells were plated on coverslips coated with poly-D-lysine (Becton Dickinson, Franklin Lakes, NJ, USA) or 0.5 mg/ml collagen (Inamed Biomaterials, Fremont, CA, USA). After incubation, the cells were fixed with 4% formaldehyde for 30 min. Cells were scored as spread when extensions of the membrane were visible and not spread when they were attached with no visible membrane protrusion. For wound-healing assay, a MEF monolayer was scratched with a pipette tip in DME medium NHERF1 stabilizes b-catenin/E-cadherin complexes EL Kreimann et al containing 0.5% fetal bovine serum (FBS) and 5 mg/ml mitomycin C (Sigma, St Louis, MO, USA) to prevent proliferation during migration.
Cell lysis and protein analysis Cell lysis, overlay assay, immunoprecipitation and immunoblotting were performed as described previously (Georgescu et al., 1999; Takahashi et al., 2006) . Antibodies are specified in Supplementary material. For cell fractionation, 4 Â 10 6 cells were homogenized in 1 ml of hypotonic buffer (10 mM HEPES, pH 7.5, 10 mM KCl, and 3 mM MgCl 2 ). After centrifugation (600 g, 5 min), the supernatant SN1 was centrifuged (100 000 g, 1 h) and the resulting SN2 represented the cytoplasmic fraction. The pellet P2 was resuspended in membrane solubilization buffer (10 mM Tris-HCl pH 7.4, 500 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA) and 1% Triton X-100) and centrifuged (16 000 g, 30 min). The supernatant S3 corresponded to the membrane fraction and the pellet P3 to the cytoskeleton. The initial pellet P1 was resuspended in 10 buffer volumes (50 mM HEPES, pH 7.9, 250 mM KCl, 0.1% NP40, 0.1 mM (ethylene glycol bis(b-aminoethylether)-N,N,N 0 ,N 0 ,-tetraacetic acid), 0.1 mM EDTA and 10% glycerol) and centrifuged (16 000 g, 10 min). The resulting supernatant corresponded to the nuclear fraction and the pellet to the debris. All procedures were performed on ice and all buffers contained protease and phosphatase inhibitors (Georgescu et al., 1999) . The BBM purification was performed as described previously (Morales et al., 2004) .
Biotinylation of membrane proteins
Confluent cultures were washed three times with ice-cold phosphate buffered saline PBS (pH 8) and biotinylated on ice with 0.5 mg/ml EZ-Link Sulfo-NHS-Biotin (Pierce, Rockford, IL, USA) in PBS for 30 min. The biotin excess was washed twice with ice-cold PBS containing 100 mM glycine. The cells were lysed, and 0.5 mg of proteins was incubated with streptavidin immobilized on Agarose CL-4B beads (Biochemika, St Louis, MO, USA) overnight at 41C.
Immunofluorescence analysis
Immunofluorescence analysis of MEFs plated on poly-Dlysine-coated coverslips was performed as described previously (Takahashi et al., 2006) . For mouse intestine, paraffin blocks were prepared from 9-week-old NHERF1( þ / þ ) and (À/À) littermates and stained as described previously (Morales et al., 2004) . Antibodies are specified in Supplementary material.
Luciferase assay
Immortalized 5 Â 10 4 MEFs per well were serum-deprived and cotransfected with 0.5 mg of either TOP or FOP luciferase (gift from Barry Gumbiner) and 0.05 mg of renilla luciferase using 2 ml/well Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). After 48 h, the cells were prepared using the Dual Luciferase Reporter assay system (Promega, Madison, WI, USA), according to the manufacturer's instructions. 
